 |
| Dr. Gary Kohls |
Myth # 1:
“The FDA (US Food and Drug Administration) tests all new psychiatric drugs”
False. Actually
the FDA only reviews studies that were designed, administered, secretly
performed and paid for by the multinational profit-driven drug
companies. The studies are frequently farmed out by the pharmaceutical
companies by well-paid research firms, in whose interest it is to find
positive results for their corporate employers. Unsurprisingly, such
research policies virtually guarantee fraudulent results.
Myth # 2:
“FDA approval means that a psychotropic drug is effective long-term”
False. Actually,
FDA approval doesn’t even mean that psychiatric drugs have been proven
to be safe – either short-term or long-term! The notion that FDA
approval means that a psych drug has been proven to be effective is also
a false one, for most such drugs are never tested – prior to marketing –
for longer than a few months (and most psych patients take their drugs
for years). The pharmaceutical industry pays many psychiatric
“researchers” – often academic psychiatrists (with east access to
compliant, chronic, already drugged-up patients) who have financial or
professional conflicts of interest – some of them even sitting on FDA
advisory committees who attempt to “fast track” psych drugs through the
approval process. For each new drug application, the FDA only receives 1
or 2 of the “best” studies (out of many) that purport to show
short-term effectiveness. The negative studies are shelved and not
revealed to the FDA. In the case of the SSRI drugs, animal lab studies
typically lasted only hours, days or weeks and the human clinical
studies only lasted, on average, 4- 6 weeks, far too short to draw any
valid conclusions about long-term effectiveness or safety!
Hence the FDA, prescribing physicians and patient-victims should not
have been “surprised” by the resulting epidemic of SSRI drug-induced
adverse reactions that are silently plaguing the nation. Indeed, many
SSRI trials have shown that those drugs are barely more effective than
placebo (albeit statistically significant!) with unaffordable economic
costs and serious health risks, some of which are life-threatening and
known to be capable of causing brain damage.
Myth # 3:
“FDA approval means that a psychotropic drug is safe long-term”
False. Actually,
the SSRIs and the “anti-psychotic” drugs are usually tested in human
trials for only a couple of months before being granted marketing
approval by the FDA. And the drug companies are only required to report 1
or 2 studies (even if many other studies on the same drug showed
negative, even disastrous, results). Drug companies obviously prefer
that the black box and fine print warnings associated with their drugs
are ignored by both consumers and prescribers. One only has to note how
small the print is on the commercials.
In our fast-paced shop-until-you-drop consumer society, we super-busy
prescribing physicians and physician assistants have never been fully
aware of the multitude of dangerous, potentially fatal adverse psych
drug effects that include addiction, mania, psychosis, suicidality,
worsening depression, worsening anxiety, insomnia, akathisia, brain
damage, dementia, homicidality, violence, etc, etc.
But when was the last time anybody heard the FDA or Big Pharma
apologize for the damage they did in the past? And when was the last
time there were significant punishments (other than writs slaps and
“chump change” multimillion dollar fines) or prison time for the CEOs of
the guilty multibillion dollar drug companies? (
Continue Reading)
Full Article & Source:
14 Lies That Our Psychiatry Professors in Medical School Taught Us
